NCT04843371 PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
| NCT ID | NCT04843371 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tulane University |
| Condition | Valvular Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-08-20 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-08-20 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.
Eligibility Criteria
Inclusion Criteria: * Male or Female aged18 years or older. * Patients scheduled to undergo an echocardiogram at Tulane Medical Center. Exclusion Criteria: * Participants under 18 years of age. * Participants with cognitive impairments. * Participants with a physical inability to wear the Biostrap during the echocardiogram. * Individuals who cannot read, speak, and/or understand English.
Contact & Investigator
Nassir Marrouche, MD
PRINCIPAL INVESTIGATOR
Tulane University
Frequently Asked Questions
Who can join the NCT04843371 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Valvular Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04843371 currently recruiting?
Yes, NCT04843371 is actively recruiting participants. Contact the research team at mbsoul@tulane.edu for enrollment information.
Where is the NCT04843371 trial being conducted?
This trial is being conducted at New Orleans, United States, New Orleans, United States, New Orleans, United States.
Who is sponsoring the NCT04843371 clinical trial?
NCT04843371 is sponsored by Tulane University. The principal investigator is Nassir Marrouche, MD at Tulane University. The trial plans to enroll 500 participants.